000566 Hainan Haiyao
- 3.31
- -0.02-0.60%
Hainan Haiyao News
Hainan Haiyao (000566): the new generation of cochlear implants has been further enriched.
Comments on Hainan Haiyao (000566) semi-annual report: two-vote system affects short-term performance and actively promotes business transformation
KuaiBao of Hainan Marine Pharmaceutical (000566) Co., Ltd.: the proposed acquisition of Qili Pharmaceutical has remarkable synergy and multi-line layout of the company's business.
Hainan Marine Pharmaceutical (000566) first coverage report: merger and acquisition of Qili Pharmaceutical to achieve business coordination, deep layout and innovative drug research and development
Hainan Haiyao (000566) follow-up comments: pre-increase in the performance of the China report
Deepin* Company* Hainan Haiyao (000566) Review: The majority shareholders' premium offer to buy shows confidence in the company's development
[Huarong Securities] Hainan Haiyao follow-up comments: the actual controller offers to purchase, full of confidence
Hainan Haiyao (000566) follow-up comments: the actual controller's offer is full of confidence.
Depth * Company * Hainan Marine Medicine (000566) comments: flufenidone has been approved in clinical trials and is optimistic about the company's long-term development.
[bank of China International Securities] Hainan Haiyao: flufenidone has been approved in clinical trials and is optimistic about the long-term development of the company.
[Tianfeng Securities] Hainan Haiyao: Fixed increase completed, opening a new chapter in development
Hainan Haiyao (000566) Review: The completion of a fixed increase opens a new chapter in development
Semi-annual results remained stable. In the first half of 2016, the company achieved revenue, net profit after deduction of mother, and net profit after deduction of 7.62, 1.15, and 84 million yuan, respectively, year-on-year increases of -6.20%, 0.44%, -1
Hainan Haiyao (000566) Interim Report: The basic layout of the industrial chain is being formed, and the three major sectors are progressing collaboratively
[Guotai Junan] Hainan Haiyao 2016 Interim Report Review: The industrial chain layout is basically taking shape, and the three major sectors are progressing collaboratively
Hainan Haiyao (000566) Review: A powerful telemedicine health platform is poised to launch
Hainan Haiyao (000566) Annual Report Review: Rapid Performance Growth Continues to Cultivate the Big Health Industry
[Huatai Securities] Hainan Haiyao: Performance is growing rapidly, continuing to cultivate the big health industry
Hainan Haiyao (000566) Review: The fixed increase plan adjusts the majority shareholders' subscription ratio
[Southwest Securities] Hainan Haiyao: Fixed increase plan adjustment, high percentage subscription by majority shareholders
Analysis
Price Target
No Data
